The Yi–Xin–Shu (YXS) capsule, a drug suggested by traditional Chinese medicine (TCM), is commonly applied in the treatment of cardiac hypertrophy by regulating the expression of GATA4, HDAC1, and retinoblastoma (RB) and the corresponding signalling pathway. Here, GATA4 is linked to cardiac hypertrophy.